Projected Income Statement: Qiagen N.V.

Forecast Balance Sheet: Qiagen N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 1,208 876 1,174 452 239 327 235 -122
Change - -27.48% 34.02% -61.5% -47.12% 37.07% -28.13% -151.91%
Announcement Date 2/9/21 2/8/22 2/10/23 2/6/24 2/5/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Qiagen N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 132.8 189.9 129.2 149.7 167.2 174.5 183.3 194
Change - 43.01% -31.95% 15.85% 11.67% 4.41% 5.03% 5.79%
Free Cash Flow (FCF) 1 325 449.1 586 309.7 506.4 490 517.7 555.7
Change - 38.18% 30.49% -47.15% 63.48% -3.23% 5.65% 7.34%
Announcement Date 2/9/21 2/8/22 2/10/23 2/6/24 2/5/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Qiagen N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 39.98% 39.27% 36.88% 33.53% 35.5% 36.97% 37.37% 38.38%
EBIT Margin (%) 33.51% 33.53% 30.65% 26.9% 28.66% 29.63% 29.85% 30.59%
EBT Margin (%) 23.5% 27.79% 23.94% 21.87% 6.12% 25.36% 27.26% 28.46%
Net margin (%) 19.2% 22.77% 19.76% 17.37% 4.23% 20.25% 20.88% 22.24%
FCF margin (%) 17.38% 19.95% 27.37% 15.76% 25.6% 23.58% 23.52% 23.78%
FCF / Net Income (%) 90.49% 87.61% 138.47% 90.75% 605.78% 116.44% 112.62% 106.89%

Profitability

        
ROA 9.02% 8.53% 6.81% 2.75% 8.32% 7.39% 7.82% 8.42%
ROE 18.85% 17.39% 12.9% 4.69% 13.31% 13.11% 13.62% 13.52%

Financial Health

        
Leverage (Debt/EBITDA) 1.61x 0.99x 1.49x 0.69x 0.34x 0.43x 0.29x -
Debt / Free cash flow 3.72x 1.95x 2x 1.46x 0.47x 0.67x 0.45x -

Capital Intensity

        
CAPEX / Current Assets (%) 7.1% 8.43% 6.03% 7.62% 8.45% 8.4% 8.33% 8.3%
CAPEX / EBITDA (%) 17.76% 21.48% 16.36% 22.72% 23.81% 22.73% 22.29% 21.62%
CAPEX / FCF (%) 40.86% 42.29% 22.05% 48.33% 33.01% 35.62% 35.42% 34.91%

Items per share

        
Cash flow per share 1 2.073 2.92 3.296 2.049 3.004 2.849 3.139 3.373
Change - 40.89% 12.86% -37.82% 46.57% -5.13% 10.16% 7.45%
Dividend per Share 1 - - - - - 0.208 0.1883 0.13
Change - - - - - - -9.44% -30.97%
Book Value Per Share 1 13.01 14.46 16.14 16.98 15.87 17.53 18.75 20.46
Change - 11.12% 11.64% 5.21% -6.52% 10.4% 6.98% 9.14%
EPS 1 1.622 2.343 1.951 1.522 0.37 1.922 2.099 2.394
Change - 44.44% -16.74% -21.98% -75.69% 419.43% 9.23% 14.04%
Nbr of stocks (in thousands) 214,454 214,097 214,734 215,189 216,084 216,841 216,841 216,841
Announcement Date 2/9/21 2/8/22 2/10/23 2/6/24 2/5/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 23.5x 21.5x
PBR 2.58x 2.41x
EV / Sales 4.88x 4.56x
Yield 0.46% 0.42%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
45.22USD
Average target price
50.43USD
Spread / Average Target
+11.52%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. Financials Qiagen N.V.